Cognitive Enhancing Drugs

Cognitive Enhancing Drugs

by Jerry J. Buccafusco
ISBN-10:
3034896034
ISBN-13:
9783034896030
Pub. Date:
10/23/2012
Publisher:
Birkh�user Basel
ISBN-10:
3034896034
ISBN-13:
9783034896030
Pub. Date:
10/23/2012
Publisher:
Birkh�user Basel
Cognitive Enhancing Drugs

Cognitive Enhancing Drugs

by Jerry J. Buccafusco

Paperback

$109.99 Current price is , Original price is $109.99. You
$109.99 
  • SHIP THIS ITEM
    Qualifies for Free Shipping
  • PICK UP IN STORE
    Check Availability at Nearby Stores

Overview

During the past decade research into the pharmacology of cognition, particularly regarding learning and memory, has supported the concept that many potential neural targets exist for the development of cognitive-enhancing drugs. Whereas the main impetus for this research has been the ever growing population of individuals with dementing disorders such as Alzheimer‘s disease, attention is also being focused on issues relating to cognitive impairment associated with "normal" aging. This book is useful as a source of information for making informed decisions regarding the relative utility and attributes of the various neural targets that have been studied to date.


Product Details

ISBN-13: 9783034896030
Publisher: Birkh�user Basel
Publication date: 10/23/2012
Series: Milestones in Drug Therapy
Edition description: Softcover reprint of the original 1st ed. 2004
Pages: 203
Product dimensions: 6.10(w) x 9.25(h) x 0.02(d)

Table of Contents

The cholinergic hypothesis — past and present.- Drugs that target cholinesterases.- Drugs that target muscarinic cholinergic receptors.- Rationale and prospects for drugs that target nicotinic acetylcholine receptors.- Drugs that target catecholaminergic receptors.- Drugs that target serotonergic receptors.- Drugs that target ionotropic excitatory amino acid receptors.- Cognitive enhancing effects of drugs that target histamine receptors.- Peptide and steroid hormone receptors as drug targets for enhancement of learning and memory performance.- Natural products as cognition enhancing agents.- Drugs with multiple CNS targets.
From the B&N Reads Blog

Customer Reviews